Patients with Secondary Progressive MS Have a Higher Mortality than Those with Primary Progressive MS
At ECTRIMS 2024, Melinda Magyari presented a study that analyzed mortality trends in multiple sclerosis (MS) patients in Denmark using Danish Multiple Sclerosis Registry data. It showed that patients with secondary progressive MS had a significantly higher mortality risk and lived about ten years shorter than primary progressive MS patients, emphasizing the need to focus on managing this stage of MS.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in